Nirvana Life Sciences Inc.
NIRV
CNSX
| 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 33.40K | 120.10K | 44.00K | 40.80K | 36.30K |
| Depreciation & Amortization | -- | -8.60K | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 33.40K | 111.50K | 44.00K | 40.80K | 36.30K |
| Operating Income | -33.40K | -111.50K | -44.00K | -40.80K | -36.30K |
| Income Before Tax | -26.50K | -119.20K | -55.60K | -44.90K | -40.80K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -26.50K | -119.20K | -55.60K | -44.90K | -40.80K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 0.00 | -500.00 | 200.00 | 200.00 | -100.00 |
| Net Income | -26.50K | -119.60K | -55.40K | -44.80K | -40.90K |
| EBIT | -33.40K | -111.50K | -44.00K | -40.80K | -36.30K |
| EBITDA | -- | -108.20K | -40.80K | -37.50K | -33.00K |
| EPS Basic | 0.00 | -0.02 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | -0.02 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | 0.00 | -0.02 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | -0.02 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 22.82M | 4.82M | 4.82M | 4.82M | 4.82M |
| Average Diluted Shares Outstanding | 22.82M | 4.82M | 4.82M | 4.82M | 4.82M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |